Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
albendazole (Albenza) (1 trial)
artemether (1 trial)
dihydroartemisinin (1 trial)
dtap (1 trial)
folic acid (2 trials)
hepatitis a vaccine, inactivated (vaqta) (1 trial)
lumefantrine (Coartem) (1 trial)
multi-valent pneumococcal conjugate vaccine (1 trial)
piperaquine (1 trial)
pyrimethamine (daraprim) (1 trial)
sulfadoxine (1 trial)
amoxicillin (1 trial)
ampicillin (1 trial)
benzylpenicilloyl polylysine (pre-pen) (1 trial)
ceftriaxone (rocephin) (1 trial)
gentamicin (garamycin) (1 trial)
accs100 (1 trial)
calcium carbonate (1 trial)
calcium (1 trial)
iron (1 trial)
lidocaine (xylocaine) (1 trial)
prilocaine (citanest) (1 trial)
Helminthiasis (Phase 4)
Malaria (Phase 4)
Nematode Infections (Phase 4)
Pneumonia (Phase 4)
Pneumonia, Pneumococcal (Phase 4)
Trials (8 total)
Trial APIs (22 total)